etomoxir has been researched along with pifithrin in 1 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (pifithrin) | Trials (pifithrin) | Recent Studies (post-2010) (pifithrin) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 382 | 0 | 192 |
| Protein | Taxonomy | etomoxir (IC50) | pifithrin (IC50) |
|---|---|---|---|
| Luciferin 4-monooxygenase | Photinus pyralis (common eastern firefly) | 1.324 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, W; Li, J; Liao, B; Yang, J | 1 |
1 other study(ies) available for etomoxir and pifithrin
| Article | Year |
|---|---|
FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus.
Topics: Adult; Animals; Apoptosis; Benzothiazoles; Bone Density; Cross-Sectional Studies; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Epoxy Compounds; Fatty Acids, Nonesterified; Humans; Lipid Peroxidation; Male; Mice, Inbred C57BL; Middle Aged; Mitochondria; Organophosphorus Compounds; Osteoblasts; Osteogenesis; Reactive Oxygen Species; Toluene; Tumor Suppressor Protein p53; Ubiquinone | 2015 |